Why invest in Aspen?

Aspen is a global specialty and branded pharmaceutical company, intent on improving the health of patients across the world by providing high quality and affordable medicines. Headquartered in Durban, South Africa and with a 160 year heritage, we are active at every stage of the pharmaceutical value chain. The Group is uniquely diversified by geography, product and manufacturing capability, positioning us to maximise the value creation for its diverse stakeholders.

We have 70 established business operations in 55 countries and provide medicines and products in more than 150 countries. Our key business segments are Manufacturing and Commercial Pharmaceuticals comprising Regional Brands and Sterile Focus Brands that include Anaesthetics and Thrombosis

Aspen is the largest pharmaceutical company listed on the JSE Limited (share code: APN) and is a constituent of the FTSE/JSE Responsible Investment Index.

The Group operates 23 manufacturing facilities across 15 sites and holds international manufacturing approvals from some of the most stringent global regulatory agencies. Our manufacturing capabilities are scalable to demand and cover a wide variety of product-types including injectables, oral solid dose, liquids, semi-solids, steriles, biologicals and active pharmaceutical ingredients.